Discover and read the best of Twitter Threads about #indoco

Most recents (9)

Detailed Analysis on the business of #Indoco Remedies💊💊

CMP - ₹389

Like and retweet for maximum reach!!
1. Company Overview
-Indoco Remedies is a pharmaceutical company that develops and manufactures a wide range of drug products for sale in the domestic and exports market.
-In the domestic market, they have several brands like Cyclopam, Febrex Plus, Sensodent-K,
Karvol Plus, ATM, etc. which are leaders in their respective therapeutic areas. Indoco generates 7 crore prescriptions annually from over 3 lakh doctors from various specialties.
-In the export markets, they have various partnerships through which they sell their products in 55
Read 29 tweets
#Indoco Remedies’ management seems to be very optimistic about strong expansion in margins. They have an export order book of ₹150 with export margins expected to increase by 400-500 bps over the next 3 quarters. Image
They will achieve EBITDA margins over 20% in this financial year and have said that they are confident of taking margins to over 25% over the next 3 years. Image
Management has said that there is huge scope for operating leverage to play out at the Baddi facility. They expect to reach 70% capacity utilization by December 2023 Image
Read 6 tweets
1⃣ stock should do good accumulation near all time high or 52 weeks high.

Ex - #routemobile & #crest
2⃣ stock should be low market cap (less then 20k Cr.) & low free float.

Ex - #smslife
3⃣ stock should face least resistance after breakout. ( Or not face major hurdle after BO)

Ex- #uttamsugar
Read 6 tweets
Stock name – Indoco Remedies (#Indoco)

Bought now @ INR 312

Chart pattern – Around 3 years long horizontal BO on weekly closing above 317.40 (confirmation pending)

Technical target – INR 630

Time frame – Within 2 years

Stop loss – Will update once stock crosses INR 362 Image
#Indoco - Press release dated 8th December 2020

Indoco wins major tenders in Germany for Allopurinol Tablets - bseindia.com/xml-data/corpf… Image
#Indoco - Great Q2FY21 result!

bseindia.com/xml-data/corpf… Image
Read 20 tweets
The Pharma sector has been in a strong downtrend after the high of Apr'15 and has been falling in a channel. The first attempt to break out was in Sep'18 but failed. Another attempt is in progress now after the stock retested 61.8% of the entire rally from Mar'09 to Apr'15. 1/n Image
Will we see a breakout this time? No one knows, but the probability to breakout is clearly on the higher side after looking at last month's candle & the reversal level at 61.8% fib. What can one do? Start a SIP in one of the pharma funds & allocate a % depending on ur risk. 2/n
Cipla retraced 50% of the entire rally and reversed from trendline and horizontal support levels too. Awaiting breakout #CIPLA #trendlines #investing #fibonacci Image
Read 9 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!